
Lori Lynn Baker
Examiner (ID: 17012, Phone: (571)272-4971 , Office: P/3754 )
| Most Active Art Unit | 3754 |
| Art Unit(s) | 3764, 3754, 3751 |
| Total Applications | 2962 |
| Issued Applications | 2221 |
| Pending Applications | 186 |
| Abandoned Applications | 595 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20510100
[patent_doc_number] => 20260034199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-02-05
[patent_title] => Methods Of Treating Plantar Fibromatosis
[patent_app_type] => utility
[patent_app_number] => 19/288143
[patent_app_country] => US
[patent_app_date] => 2025-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 84885
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19288143
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/288143 | Methods Of Treating Plantar Fibromatosis | Jul 31, 2025 | Pending |
Array
(
[id] => 20321351
[patent_doc_number] => 20250333439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-30
[patent_title] => PURIFIED PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 19/264681
[patent_app_country] => US
[patent_app_date] => 2025-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55674
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19264681
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/264681 | PURIFIED PROTEIN COMPOSITIONS AND METHODS OF PRODUCTION | Jul 8, 2025 | Pending |
Array
(
[id] => 20480581
[patent_doc_number] => 12529052
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-20
[patent_title] => Euglobulin-based method for determining the biological activity of defibrotide
[patent_app_type] => utility
[patent_app_number] => 19/173657
[patent_app_country] => US
[patent_app_date] => 2025-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 1354
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19173657
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/173657 | Euglobulin-based method for determining the biological activity of defibrotide | Apr 7, 2025 | Issued |
Array
(
[id] => 20492859
[patent_doc_number] => 12534722
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Euglobulin-based method for determining the biological activity of defibrotide
[patent_app_type] => utility
[patent_app_number] => 19/173652
[patent_app_country] => US
[patent_app_date] => 2025-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 1329
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19173652
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/173652 | Euglobulin-based method for determining the biological activity of defibrotide | Apr 7, 2025 | Issued |
Array
(
[id] => 20657920
[patent_doc_number] => 20260109959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-04-23
[patent_title] => METHODS OF TREATING PULMONARY SARCOIDOSIS WITH DNA NUCLEASES
[patent_app_type] => utility
[patent_app_number] => 19/031963
[patent_app_country] => US
[patent_app_date] => 2025-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1147
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19031963
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/031963 | METHODS OF TREATING PULMONARY SARCOIDOSIS WITH DNA NUCLEASES | Jan 17, 2025 | Pending |
Array
(
[id] => 19984027
[patent_doc_number] => 20250122249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-04-17
[patent_title] => PURIFICATION OF PHYCOBILIPROTEINS
[patent_app_type] => utility
[patent_app_number] => 18/910453
[patent_app_country] => US
[patent_app_date] => 2024-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18910453
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/910453 | PURIFICATION OF PHYCOBILIPROTEINS | Oct 8, 2024 | Pending |
Array
(
[id] => 19745667
[patent_doc_number] => 20250034232
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => von Willebrand Factor Proteins for Treating Bleeding Disorders
[patent_app_type] => utility
[patent_app_number] => 18/883537
[patent_app_country] => US
[patent_app_date] => 2024-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10740
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18883537
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/883537 | von Willebrand Factor Proteins for Treating Bleeding Disorders | Sep 11, 2024 | Pending |
Array
(
[id] => 20179811
[patent_doc_number] => 20250263769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => METHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEINS BY RECOMBINANT METHODS
[patent_app_type] => utility
[patent_app_number] => 18/821185
[patent_app_country] => US
[patent_app_date] => 2024-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5548
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821185
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/821185 | METHOD OF PRODUCING BIOLOGICALLY ACTIVE VITAMIN K DEPENDENT PROTEINS BY RECOMBINANT METHODS | Aug 29, 2024 | Pending |
Array
(
[id] => 19642907
[patent_doc_number] => 20240417427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances
[patent_app_type] => utility
[patent_app_number] => 18/817164
[patent_app_country] => US
[patent_app_date] => 2024-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41799
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18817164
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/817164 | Integrated Continuous Manufacturing of Therapeutic Protein Drug Substances | Aug 26, 2024 | Pending |
Array
(
[id] => 20100490
[patent_doc_number] => 20250230426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-17
[patent_title] => RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME
[patent_app_type] => utility
[patent_app_number] => 18/815115
[patent_app_country] => US
[patent_app_date] => 2024-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18815115
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/815115 | RECOMBINANT VITAMIN K DEPENDENT PROTEINS WITH HIGH SIALIC ACID CONTENT AND METHODS OF PREPARING SAME | Aug 25, 2024 | Pending |
Array
(
[id] => 19629568
[patent_doc_number] => 20240408017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => THROMBOLYTIC MICROSPHERES TO DISSOLVE VASO-OCCLUSIVE CLOTS
[patent_app_type] => utility
[patent_app_number] => 18/812320
[patent_app_country] => US
[patent_app_date] => 2024-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17704
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18812320
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/812320 | THROMBOLYTIC MICROSPHERES TO DISSOLVE VASO-OCCLUSIVE CLOTS | Aug 21, 2024 | Pending |
Array
(
[id] => 19629733
[patent_doc_number] => 20240408182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => COMPOSITIONS AND METHODS FOR BIODEGRADING ALCOHOL
[patent_app_type] => utility
[patent_app_number] => 18/811618
[patent_app_country] => US
[patent_app_date] => 2024-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18811618
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/811618 | COMPOSITIONS AND METHODS FOR BIODEGRADING ALCOHOL | Aug 20, 2024 | Pending |
Array
(
[id] => 19691312
[patent_doc_number] => 20250009857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => NUTRACEUTICAL COMPOSITION BASED ON PINEAPPLE AND PLANT EXTRACTS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME
[patent_app_type] => utility
[patent_app_number] => 18/765199
[patent_app_country] => US
[patent_app_date] => 2024-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18765199
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/765199 | NUTRACEUTICAL COMPOSITION BASED ON PINEAPPLE AND PLANT EXTRACTS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME | Jul 4, 2024 | Pending |
Array
(
[id] => 20445586
[patent_doc_number] => 20260002303
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2026-01-01
[patent_title] => PROCESS FOR MANUFACTURING A POTENTIATING PROTEIN COMPOSITION WITH INCREASED EFFICIENCY AND LONGEVITY AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/756409
[patent_app_country] => US
[patent_app_date] => 2024-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18756409
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/756409 | PROCESS FOR MANUFACTURING A POTENTIATING PROTEIN COMPOSITION WITH INCREASED EFFICIENCY AND LONGEVITY AND USES THEREOF | Jun 26, 2024 | Pending |
Array
(
[id] => 19512086
[patent_doc_number] => 20240343772
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => Fusion protein and its preparation method for intermediate polypeptide of Semaglutide
[patent_app_type] => utility
[patent_app_number] => 18/755691
[patent_app_country] => US
[patent_app_date] => 2024-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18755691
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/755691 | Fusion protein and its preparation method for intermediate polypeptide of Semaglutide | Jun 26, 2024 | Issued |
Array
(
[id] => 20427647
[patent_doc_number] => 20250389737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-25
[patent_title] => FACTOR Xa REAGENT
[patent_app_type] => utility
[patent_app_number] => 18/748840
[patent_app_country] => US
[patent_app_date] => 2024-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18748840
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/748840 | FACTOR Xa REAGENT | Jun 19, 2024 | Pending |
Array
(
[id] => 19601449
[patent_doc_number] => 20240392329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES
[patent_app_type] => utility
[patent_app_number] => 18/737619
[patent_app_country] => US
[patent_app_date] => 2024-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 111984
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18737619
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/737619 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES | Jun 6, 2024 | Abandoned |
Array
(
[id] => 20330818
[patent_doc_number] => 12461089
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-04
[patent_title] => Olfactory receptor involved in the perception of musk fragrance and the use thereof
[patent_app_type] => utility
[patent_app_number] => 18/406031
[patent_app_country] => US
[patent_app_date] => 2024-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 21
[patent_no_of_words] => 17645
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18406031
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/406031 | Olfactory receptor involved in the perception of musk fragrance and the use thereof | May 29, 2024 | Issued |
Array
(
[id] => 19862606
[patent_doc_number] => 20250101392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-27
[patent_title] => Enzyme Variants With Improved Ester Synthase Properties
[patent_app_type] => utility
[patent_app_number] => 18/662446
[patent_app_country] => US
[patent_app_date] => 2024-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39913
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18662446
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/662446 | Enzyme variants with improved ester synthase properties | May 12, 2024 | Issued |
Array
(
[id] => 19543456
[patent_doc_number] => 20240360492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => COAGULATION AND FIBRINOLYSIS ASSAYS
[patent_app_type] => utility
[patent_app_number] => 18/657130
[patent_app_country] => US
[patent_app_date] => 2024-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14351
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18657130
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/657130 | COAGULATION AND FIBRINOLYSIS ASSAYS | May 6, 2024 | Pending |